截至2025年12月26日收盘，伟思医疗（688580）报收于48.07元，较上周的46.61元上涨3.13%。本周， 伟思医疗12月25日盘中最高价报50.2元。12月24日盘中最低价报45.79元。伟思医疗当前最新总市值 46.04亿元，在医疗器械板块市值排名77/127，在两市A股市值排名3559/5178。 南京伟思医疗科技股份有限公司拟以11,900万元的价格，将其持有的位于南京市雨花台区宁双路19号9 幢的房屋及配套固定资产转让给江苏云智汇创业投资有限公司。标的资产账面净值为7,994.86万元（截 至2025年9月30日），产权清晰，无抵押或限制转让情形。本次交易不构成关联交易或重大资产重组， 已获董事会审议通过，无需提交股东大会审议。交易预计对公司2026年度归母净利润影响约1,000万 元，对2025年无影响。款项分四期支付，需完成产权过户及资产交割。交易尚存履约不确定性，敬请投 资者注意风险。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 公司公告汇总：伟思医疗拟以1.19亿元出售南京雨花台区办公总部资产。 公 ...

证券代码：688580 证券简称：伟思医疗 公告编号：2025-045 一、交易概述 南京伟思医疗科技股份有限公司 关于出售资产的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 交易简要内容:南京伟思医疗科技股份有限公司（以下简称："公司"或"伟思医疗"）拟以总价人民币 11,900 万元的价格，将其持有的位于南京市雨花台区宁双路19号9幢 的房屋及楼宇部分配套固定资产 （以下简称"标的资产"）转让给江苏云智汇创业投资有限公司（以下简称"本次交易"）。 ● 本次交易不构成关联交易 ● 本次交易不构成重大资产重组 ● 交易实施尚需履行的审批及其他相关程序：本次交易已经公司第四届董事会第八次会议审议通过，根 据《上海证券交易所科创板股票上市规则》的规定，该议案无需提交股东会审议。后续交易双方将按照 签署的《南京市存量房买卖合同》、《固定资产买卖合同》约定办理资产交付等事宜。 ● 风险提示：经公司初步估算，本次交易预计对公司2026年度归属于上市公司股东的净利润影响金额约 为1,000万元（未经审计），对2 ...

Core Viewpoint - Weisi Medical (688580.SH) has successfully completed the construction acceptance of its new headquarters, the "Weisi Medical Headquarters R&D Economic Park," which is expected to enhance operational efficiency and support the company's high-quality development [1] Group 1: New Headquarters Development - The new headquarters is located at No. 1 Shuo Guo Road, Yuhua District, Nanjing, covering an area of approximately 24,000 square meters with a total construction area of nearly 70,000 square meters [1] - The facility integrates high-end research and development, intelligent manufacturing, and modern office functions, significantly improving the office environment, production capacity, research infrastructure, and intelligence level compared to the current location [1] - The company plans to complete the overall relocation by the first half of 2026, which will provide a solid foundation for its high-quality development [1] Group 2: Asset Optimization and Financial Strategy - To optimize its asset structure and enhance resource allocation efficiency, the company plans to dispose of its current headquarters located at No. 19 Ning Shuang Road, Yuhua District, Nanjing [1] - The agreed total transfer price for the disposal of the property and associated facilities is RMB 119 million (equivalent to 11,900 million yuan) [1] - This disposal will help activate existing assets, address potential idle issues post-relocation, reduce operational costs, and recover funds for the new headquarters operations and core business development, aligning with the company's long-term strategy and benefiting all shareholders [1]